APA (7th ed.) Citation

S, Y., J, C., E, C., E, H., N, J., M, C. M., . . . C, E. (2025). Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): A multicentre, randomised controlled trial. The Lancet. Digital health, 7(5), 100866. https://doi.org/10.1016/j.landig.2025.02.006

Chicago Style (17th ed.) Citation

S, Yun, et al. "Evaluation of Mobile Health Technology Combining Telemonitoring and Teleintervention Versus Usual Care in Vulnerable-phase Heart Failure Management (HERMeS): A Multicentre, Randomised Controlled Trial." The Lancet. Digital Health 7, no. 5 (2025): 100866. https://doi.org/10.1016/j.landig.2025.02.006.

MLA (9th ed.) Citation

S, Yun, et al. "Evaluation of Mobile Health Technology Combining Telemonitoring and Teleintervention Versus Usual Care in Vulnerable-phase Heart Failure Management (HERMeS): A Multicentre, Randomised Controlled Trial." The Lancet. Digital Health, vol. 7, no. 5, 2025, p. 100866, https://doi.org/10.1016/j.landig.2025.02.006.